BridgeBio Pharma, Inc. (FRA:2CL)
Germany · Delayed Price · Currency is EUR 63.52
-1.44 (-2.22%)
Last updated: Jan 28, 2026, 3:58 PM CET
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €12.53 billion as of January 30, 2026. Its market cap has increased by 94.96% in one year.
Market Cap
12.53B
Enterprise Value
13.56B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€63.52
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.53B, an increase of 329.12%. That is a compound annual growth rate of 24.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 12.53B | -0.17% |
| Dec 31, 2025 | 12.55B | 150.63% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.19B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |